MCI — Medcaw Investments Income Statement
0.000.00%
Last trade - 00:00- £0.69m
- £0.52m
Annual income statement for Medcaw Investments, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||
| Total Operating Expenses | 0.066 | 0.194 | 0.712 |
| Operating Profit | -0.066 | -0.194 | -0.712 |
| Net Income Before Taxes | -0.066 | -0.194 | -0.712 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -0.066 | -0.194 | -0.712 |
| Net Income Before Extraordinary Items | |||
| Net Income | -0.066 | -0.194 | -0.712 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -0.066 | -0.194 | -0.712 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.004 | -0.011 | -0.036 |